|
Market Closed -
OTC Markets
10:45:54 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 7.150 USD | -1.24% |
|
-1.24% | +64.37% |
| 09-02 | Knight Therapeutics Gets Regulatory Approval for TAVALISSE in Colombia | MT |
| 09-01 | Knight Therapeutics Announces Regulatory Approval of Tavalisse in Colombia | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Knight Therapeutics Inc.(GUD)
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- GUD Stock
- KHTRF Stock
- Consensus Knight Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
